Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H-PROOF is a consumer health company specializing in doctor-formulated supplements designed to support alcohol metabolism and mitigate the effects of hangovers. Founded by board-certified surgeon Dr. Linda Kaplan and her daughter Rachel Kaplan, the company's flagship product is 'The Anytime Chewable,' a tablet containing a blend of vitamins, minerals, and antioxidants. The formulation is designed to promote the activity of enzymes like alcohol dehydrogenase and acetaldehyde dehydrogenase, which break down alcohol's toxic byproducts. H-PROOF positions itself as a science-backed alternative in the wellness and recovery market. The company gained significant public attention following an appearance on the television show Shark Tank, where it secured investment to scale its operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H-PROOF.